Scylla and Charybdis: Unpalatable choices in managing hypodiploid acute lymphoblastic leukemia
Acquired TP53 alterations are present in > 90% of cases of paediatric low-hypodiploid acute lymphoblastic leukaemia (ALL), and ≈ 50% of patients with this subtype harbor germline pathogenic / likely pathogenic (P/LP) TP53 alterations. Despite dose intensified, conventional chemotherapy, survival...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Jezik: | English |
Izdano: |
Elsevier
2023-12-01
|
Serija: | EJC Paediatric Oncology |
Teme: | |
Online dostop: | http://www.sciencedirect.com/science/article/pii/S2772610X23001319 |